Kun Zhang

Peking University Third Hospital, Beijing, Beijing Shi, China

Are you Kun Zhang?

Claim your profile

Publications (3)0.18 Total impact

  • Article: [Analysis of mesh related complications after trans-vaginal mesh-augmented pelvic floor reconstruction surgery.]
    [show abstract] [hide abstract]
    ABSTRACT: OBJECTIVE: To evaluate the complications after trans-vaginal mesh-augmented pelvic floor reconstruction in treatment of pelvic organ prolapse (POP). METHODS: From February 2007 to October 2009, vaginal mesh procedures were performed on 91 women with POP stage III-IV in Peking University Third Hospital. The operative complications were studied. RESULTS: Ninety patients underwent successful surgery among 91 patients. Follow-up rate was 94% (85/90) at a median follow-up of 28.4 (15 - 44) months. One patient underwent intraoperative organ injuries, and 10 patients had postoperation mesh-related complications. The rate of mesh-related complications was 2% (2/85), 2% (2/85), 4% (3/85), 4% (3/85) on 6, 6 - 12, 12 - 24 and more than 24 months following up, respectively. Seven patients underwent conservative treatment and the symptoms were improved. Three patients underwent the second surgery, and the symptoms were cured or relieved. CONCLUSION: The incidence of mesh-related complications was low, and interventions were effective in vaginal mesh procedure.
    Zhonghua fu chan ke za zhi 09/2012; 47(9):669-671.
  • Article: Cervical adenosarcoma: Report of a case and literature review
    [show abstract] [hide abstract]
    ABSTRACT: Cervical adenosarcoma was an extremely rare kind of Mullerian mixed tumor, and there was no optimal method of treatment. The aim of this article was to approach the better treatment method for this kind of disease. In this paper, the vaginal touch, the MRI image, and biopsy were used for diagnosis. And a conservative surgery was performed, followed by 4 cycles of VAC (VCR+KSM+CTX) chemotherapy. No evidence of recurrence was seen during follow-up till now. The conservative surgery and VAC chemotherapy in this patient was effective. Key wordsCervical adenosarcoma CLC numberR737.33
    Chinese Journal of Cancer Research 04/2012; 22(3):235-238. · 0.18 Impact Factor
  • Article: [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse].
    [show abstract] [hide abstract]
    ABSTRACT: To evaluate clinical outcome and complications of mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse. From Feb 2007 to Jan 2009, mesh-augmented vaginal reconstructive surgery were performed on 66 women with pelvic organ prolapse stage III-IV. Pre and postoperative symptoms, pelvic organ prolapse quantitation (POP-Q) stage and pelvic floor distress inventory-short form 20 (PFDI-20) measurements were studied to assess anatomic and quality-of-life outcome. Operative complications were also analyzed. Totally 65 patients underwent successful surgeries. The rate of follow-up was 97% (63/65) with a median follow-up of 17.2 months. Subjective cure rate and objective cure rate were both 97% (61/63) at 6 and 12 months after surgeries, 51 women completed PFDI-20 measurements and scores were 102 ± 50 before surgery, 16 ± 21 at 6 months and 15 ± 20 at 12 months. It reached statistical difference when scores were compared before and after surgeries (P < 0.05). Among 66 patients, 2 patients underwent organ injuries, 2 had recurrent prolapse, 4 had mesh-related complications and 1 had severe de novo stress urinary incontinence. Six patients underwent second surgery. Mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapsed brought satisfied clinical outcome. The incidence of mesh-related complications was low and secondary operative interventions were effective.
    Zhonghua fu chan ke za zhi 02/2011; 46(2):101-4.